American Premium Water Corporation (OTC PINK:HIPH) announced yesterday that Goldman Small Cap Research, a sponsored research provider focused on microcap stocks, has issued a new research update this morning. This update highlights the impact of the Company closing its distribution agreement with Q4 Sports (www.q4sports.com). In the sponsored research update, analyst Rob Goldman affirms his price target of $0.0125 and his investment thesis, noting that the news reflects a milestone event that is wide-reaching for the Company in terms of revenue, cross-selling opportunities, and a reach into new markets.
“In our view, this news serves as a transformational event for HIPH. First, it will foster cross-selling opportunities for HIPH that leverages the Q4 platform which could evolve into new, additional distribution. Second, HIPH can now reach a diverse and new demographics for its CBD offerings—that has heretofore not been widely targeted by HIPH’s peers, ” according to the Goldman Small Cap Research update.
Goldman also cited in the update that since his initiation of coverage report released on February 13, 2020, the HIPH stock price has already risen by 28%, with room to move much higher, based on future business development and revenue expectations. Both the report and the update, along with the associated disclosure and disclaimers can be read or downloaded on the Goldman Small Cap Research website here.
American Premium Water Corp. made significant acquisitions and partnerships so far this year, earlier this week, the company announced that it has closed the transaction with a definitive agreement to acquire domestic distribution rights for Q4 Sports (www.q4sports.com) for a one year period that can be extended upon the consent of the Company and Q4 and also recently announced that its LALPINA CBD will now be sold in 7-Eleven. The product will initially be sold at the 7-Eleven located at 11401 Ventura Blvd, North Hollywood, CA 91604. This location is part of a 25-store network owned by an individual franchisee, who is a part of the chain’s 7800+ network of stores in the United States. This development is part of 7-Eleven’s initiative to be a front-running retailer in the consumer CBD market.
After acquiring PlantBodyEssentials earlier in 2019, the company announced last month that they will launch sales with four products, three complimentary CBD-infused topical balms and one CBD-infused lip balm. The Company is also in discussions with retailers and distributors to sell the brand in stores.This is another step towards generating revenue for the Company and monetizing the Company’s assets. The plant + body product is exceptional and is priced competitively with comparable products.
This diversification strategy is establishing HIPH as a CBD conglomerate, giving it various revenue streams in the CBD space. This push to become a market leader in the CBD and cannabis cosmetic space separates HIPH from its beverage peer group and makes it a very compelling value investment.